IDEXX Laboratories, Inc.

At $698.55, IDEXX Laboratories' price is 30% above the $539.29 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 47.07 times earnings and 42.21 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

Intrinsiqq's calculator puts IDEXX Laboratories' fair value at $539.29 a share. It grows earnings per share 14.3% a year for 5 years, applies an exit P/E of 30, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $404.47. Every input can be changed on the Intrinsic Value tab.

IDEXX Laboratories scores 80 out of 100 on Intrinsiqq's quality score, which makes it a high-quality business on these measures. The score blends 8 checks computed from SEC filings. Its best check is cash flow growth at 34.9%, and its weakest is revenue growth at 8.5%. The Quality tab shows every check against its target.

No. IDEXX Laboratories (IDXX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Over the last twelve months it returned cash through share buybacks instead, equal to a 1.9% buyback yield. The Dividends tab shows its cash returns.